Cargando…
Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
Establishing how many people have been infected by SARS-CoV-2 remains an urgent priority for controlling the COVID-19 pandemic. Serological tests that identify past infection can be used to estimate cumulative incidence, but the relative accuracy and robustness of various sampling strategies have be...
Autores principales: | Larremore, Daniel B, Fosdick, Bailey K, Bubar, Kate M, Zhang, Sam, Kissler, Stephen M, Metcalf, C Jessica E, Buckee, Caroline O, Grad, Yonatan H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979159/ https://www.ncbi.nlm.nih.gov/pubmed/33666169 http://dx.doi.org/10.7554/eLife.64206 |
Ejemplares similares
-
Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics
por: Ma, Kevin C, et al.
Publicado: (2021) -
Geographically skewed recruitment and COVID-19 seroprevalence estimates: a cross-sectional serosurveillance study and mathematical modelling analysis
por: Brown, Tyler, et al.
Publicado: (2023) -
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
por: Bubar, Kate M., et al.
Publicado: (2021) -
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
por: Bubar, Kate M., et al.
Publicado: (2021) -
Targeted surveillance strategies for efficient detection of novel antibiotic resistance variants
por: Hicks, Allison L, et al.
Publicado: (2020)